GFM
GF Fund Management Portfolio holdings
AUM
$4.97B
This Quarter Return
+21.29%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$4.97B
AUM Growth
+$710M
(+17%)
Cap. Flow
+$57.6M
Cap. Flow
% of AUM
1.16%
Top 10 Holdings %
Top 10 Hldgs %
43.85%
Holding
701
New
35
Increased
130
Reduced
246
Closed
41
Top Buys
| 1 |
British American Tobacco
BTI
|
$31.2M |
| 2 |
SAP
SAP
|
$28.7M |
| 3 |
Robinhood
HOOD
|
$28.4M |
| 4 |
UnitedHealth
UNH
|
$25.3M |
| 5 |
Celestica
CLS
|
$20.1M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$36.5M |
| 2 |
TSMC
TSM
|
$32.1M |
| 3 |
Meta Platforms (Facebook)
META
|
$28.1M |
| 4 |
KE Holdings
BEKE
|
$20.4M |
| 5 |
Trip.com Group
TCOM
|
$16.6M |
Sector Composition
| 1 | Technology | 46.23% |
| 2 | Consumer Discretionary | 14.24% |
| 3 | Communication Services | 13.85% |
| 4 | Consumer Staples | 7.1% |
| 5 | Healthcare | 7.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Universal Health Services
UHS
$12.1B
| $255K | 0.01% |
1,406
-10
| -0.7% | -$1.81K |
|
302
Kimco Realty
KIM
$15.4B
| $252K | 0.01% |
11,985
-782
| -6% | -$16.4K |
|
303
Kosmos Energy
KOS
$784M
| $252K | 0.01% |
146,322
+8,507
| +6% | +$14.6K |
|
304
Medpace
MEDP
$13.7B
| $250K | 0.01% |
796
| – | – |
|
|
TEM
305
Tempus AI, Inc. Class A Common Stock
TEM
$13.8B
| $248K | 0.01% |
3,902
| – | – |
|
306
W.P. Carey
WPC
$14.9B
| $241K | ﹤0.01% |
3,862
-283
| -7% | -$17.7K |
|
307
UDR
UDR
$13B
| $227K | ﹤0.01% |
5,550
-387
| -7% | -$15.8K |
|
308
Gaming and Leisure Properties
GLPI
$13.7B
| $226K | ﹤0.01% |
4,848
-349
| -7% | -$16.3K |
|
309
REX American Resources
REX
$1.02B
| $218K | ﹤0.01% |
4,470
-145
| -3% | -$7.06K |
|
310
Regency Centers
REG
$13.4B
| $217K | ﹤0.01% |
3,042
-224
| -7% | -$16K |
|
311
Healthpeak Properties
DOC
$12.8B
| $216K | ﹤0.01% |
12,322
-926
| -7% | -$16.2K |
|
312
Camden Property Trust
CPT
$11.9B
| $212K | ﹤0.01% |
1,883
-138
| -7% | -$15.6K |
|
313
American Homes 4 Rent
AMH
$12.9B
| $212K | ﹤0.01% |
5,866
-422
| -7% | -$15.2K |
|
314
Roivant Sciences
ROIV
$8.82B
| $210K | ﹤0.01% |
18,641
| – | – |
|
315
BridgeBio Pharma
BBIO
$10.2B
| $209K | ﹤0.01% |
4,839
| – | – |
|
|
BPMC
316
DELISTED
Blueprint Medicines
BPMC
| $208K | ﹤0.01% |
1,626
| – | – |
|
317
Henry Schein
HSIC
$8.42B
| $203K | ﹤0.01% |
2,781
-20
| -0.7% | -$1.46K |
|
318
Bio-Techne
TECH
$8.46B
| $201K | ﹤0.01% |
3,900
-29
| -0.7% | -$1.49K |
|
319
Sezzle
SEZL
$2.92B
| $200K | ﹤0.01% |
+1,118
| New | +$200K |
|
320
Alexandria Real Estate Equities
ARE
$14.5B
| $200K | ﹤0.01% |
2,748
-231
| -8% | -$16.8K |
|
321
Equity Lifestyle Properties
ELS
$12B
| $198K | ﹤0.01% |
3,203
-235
| -7% | -$14.5K |
|
322
Host Hotels & Resorts
HST
$12B
| $188K | ﹤0.01% |
12,228
-1,012
| -8% | -$15.5K |
|
323
SoFi Technologies
SOFI
$30.7B
| $187K | ﹤0.01% |
10,248
-31,456
| -75% | -$573K |
|
324
Charles River Laboratories
CRL
$8.07B
| $185K | ﹤0.01% |
1,222
-9
| -0.7% | -$1.37K |
|
325
Vitesse Energy
VTS
$986M
| $183K | ﹤0.01% |
8,283
+1,005
| +14% | +$22.2K |
|